{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,3]],"date-time":"2026-11-03T03:03:36Z","timestamp":1793675016417,"version":"4.5.1"},"reference-count":42,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,2,16]],"date-time":"2021-02-16T00:00:00Z","timestamp":1613433600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2021,2,16]],"date-time":"2021-02-16T00:00:00Z","timestamp":1613433600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Immunol"],"published-print":{"date-parts":[[2021,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p><jats:bold>C<\/jats:bold>D100 is an immune semaphorin family member that highly expressed on T cells, which take part in the development of acute myocardial infarction (AMI). Matrix metalloproteinases (MMPs) are important mediators for membrane-bound CD100 (mCD100) shedding from T cells to generate soluble CD100 (sCD100), which has immunoregulatory effect on T cells. The aim of this study was to investigate modulatory role of CD100 on CD8<jats:sup>+<\/jats:sup> T cell activity in AMI patients.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>Peripheral sCD100 and MMP-2 level, as well as mCD100 level on T cells was assessed in patients with stable angina pectoris (SAP), unstable angina pectoris (UAP), and AMI. The regulatory function of MMP-2 on mCD100 shedding, sCD100 formation, and cytotoxicity of CD8<jats:sup>+<\/jats:sup> T cells was analyzed in direct and indirect contact co-culture system.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>AMI patients had higher peripheral sCD100 and lower mCD100 expression on CD8<jats:sup>+<\/jats:sup> T cells in comparison with SAP, UAP, and controls. CD8<jats:sup>+<\/jats:sup> T cells in AMI patients showed elevated direct cytotoxicity, enhanced cytokine production, and increased perforin\/granzyme B secretion. Recombinant sCD100 stimulation promoted cytolytic function of CD8<jats:sup>+<\/jats:sup> T cells in controls and AMI patients. Furthermore, AMI patients also had elevated circulating MMP-2 level. Recombinant MMP-2 stimulation induced mCD100 shedding from CD8<jats:sup>+<\/jats:sup> T cells and sCD100 generation, resulting in enhancement of CD8<jats:sup>+<\/jats:sup> T cell cytotoxicity in AMI patients.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusion<\/jats:title>\n                <jats:p>Up-regulation of MMP-2 might contribute to elevation of mCD100 shedding and sCD100 formation, leading to increased cytotoxicity CD8<jats:sup>+<\/jats:sup> T cells in AMI patients.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12865-021-00406-y","type":"journal-article","created":{"date-parts":[[2021,2,17]],"date-time":"2021-02-17T17:21:36Z","timestamp":1613582496000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":12,"title":["CD100 modulates cytotoxicity of CD8+ T cells in patients with acute myocardial infarction"],"prefix":"10.1186","volume":"22","author":[{"given":"Yan","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li","family":"Qin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qijun","family":"Bai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jingjing","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruixue","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kunpeng","family":"Song","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,2,16]]},"reference":[{"issue":"12","key":"406_CR1","doi-asserted-by":"publisher","first-page":"1852","DOI":"10.1161\/CIRCRESAHA.114.302721","volume":"114","author":"JF Bentzon","year":"2014","unstructured":"Bentzon JF, Otsuka F, Virmani R, Falk E. Mechanisms of plaque formation and rupture. Circ Res. 2014;114(12):1852\u201366.","journal-title":"Circ Res"},{"issue":"9","key":"406_CR2","doi-asserted-by":"publisher","first-page":"e771","DOI":"10.4244\/EIJ-D-18-01175","volume":"15","author":"C Wang","year":"2019","unstructured":"Wang C, Hu S, Wu J, Yu H, Pan W, Qin Y, He L, Li L, Hou J, Zhang S, et al. Characteristics and significance of healed plaques in patients with acute coronary syndrome and stable angina: an in vivo OCT and IVUS study. EuroIntervention. 2019;15(9):e771\u20138.","journal-title":"EuroIntervention"},{"issue":"1","key":"406_CR3","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1161\/CIRCRESAHA.118.311098","volume":"124","author":"P Libby","year":"2019","unstructured":"Libby P, Pasterkamp G, Crea F, Jang IK. Reassessing the mechanisms of acute coronary syndromes. Circ Res. 2019;124(1):150\u201360.","journal-title":"Circ Res"},{"issue":"2","key":"406_CR4","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1161\/CIRCRESAHA.118.313591","volume":"124","author":"D Wolf","year":"2019","unstructured":"Wolf D, Ley K. Immunity and inflammation in atherosclerosis. Circ Res. 2019;124(2):315\u201327.","journal-title":"Circ Res"},{"issue":"3","key":"406_CR5","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1160\/TH12-05-0341","volume":"108","author":"P Matusik","year":"2012","unstructured":"Matusik P, Guzik B, Weber C, Guzik TJ. Do we know enough about the immune pathogenesis of acute coronary syndromes to improve clinical practice? Thromb Haemost. 2012;108(3):443\u201356.","journal-title":"Thromb Haemost"},{"issue":"12","key":"406_CR6","first-page":"1799","volume":"27","author":"W Elabbassi","year":"2006","unstructured":"Elabbassi W, Al-Nooryani A. Acute coronary syndrome. An acute inflammatory syndrome. Saudi Med J. 2006;27(12):1799\u2013803.","journal-title":"Saudi Med J"},{"issue":"19","key":"406_CR7","doi-asserted-by":"publisher","first-page":"2107","DOI":"10.1016\/j.jacc.2016.08.036","volume":"68","author":"D Flego","year":"2016","unstructured":"Flego D, Liuzzo G, Weyand CM, Crea F. Adaptive immunity Dysregulation in acute coronary syndromes: from cellular and molecular basis to clinical implications. J Am Coll Cardiol. 2016;68(19):2107\u201317.","journal-title":"J Am Coll Cardiol"},{"key":"406_CR8","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1016\/j.yjmcc.2013.04.023","volume":"62","author":"X Yan","year":"2013","unstructured":"Yan X, Anzai A, Katsumata Y, Matsuhashi T, Ito K, Endo J, Yamamoto T, Takeshima A, Shinmura K, Shen W, et al. Temporal dynamics of cardiac immune cell accumulation following acute myocardial infarction. J Mol Cell Cardiol. 2013;62:24\u201335.","journal-title":"J Mol Cell Cardiol"},{"issue":"2","key":"406_CR9","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1111\/apm.13094","volume":"129","author":"H Gang","year":"2021","unstructured":"Gang H, Peng D, Hu Y, Tang S, Li S, Huang Q. Interleukin-9-secreting CD4(+) T cells regulates CD8(+) T cells cytotoxicity in patients with acute coronary syndromes. APMIS. 2021;129(2):91\u2013102.","journal-title":"APMIS"},{"issue":"1\u20132","key":"406_CR10","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1615\/CritRevImmunol.v23.i12.40","volume":"23","author":"A Elhabazi","year":"2003","unstructured":"Elhabazi A, Marie-Cardine A, Chabbert-de Ponnat I, Bensussan A, Boumsell L. Structure and function of the immune semaphorin CD100\/SEMA4D. Crit Rev Immunol. 2003;23(1\u20132):65\u201381.","journal-title":"Crit Rev Immunol"},{"issue":"9","key":"406_CR11","doi-asserted-by":"publisher","first-page":"1021","DOI":"10.1134\/S0006297919090049","volume":"84","author":"EM Kuklina","year":"2019","unstructured":"Kuklina EM. Receptor functions of Semaphorin 4D. Biochemistry (Mosc). 2019;84(9):1021\u20137.","journal-title":"Biochemistry (Mosc)"},{"issue":"9","key":"406_CR12","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0075772","volume":"8","author":"MC Luque","year":"2013","unstructured":"Luque MC, Gutierrez PS, Debbas V, Martins WK, Puech-Leao P, Porto G, Coelho V, Boumsell L, Kalil J, Stolf B. Phage display identification of CD100 in human atherosclerotic plaque macrophages and foam cells. PLoS One. 2013;8(9):e75772.","journal-title":"PLoS One"},{"key":"406_CR13","doi-asserted-by":"publisher","first-page":"136","DOI":"10.3389\/fcvm.2018.00136","volume":"5","author":"MCA Luque","year":"2018","unstructured":"Luque MCA, Galuppo MK, Capelli-Peixoto J, Stolf BS. CD100 effects in macrophages and its roles in atherosclerosis. Front Cardiovasc Med. 2018;5:136.","journal-title":"Front Cardiovasc Med"},{"issue":"4","key":"406_CR14","doi-asserted-by":"publisher","first-page":"685","DOI":"10.1016\/j.jhep.2019.05.013","volume":"71","author":"S Yang","year":"2019","unstructured":"Yang S, Wang L, Pan W, Bayer W, Thoens C, Heim K, Dittmer U, Timm J, Wang Q, Yu Q, et al. MMP2\/MMP9-mediated CD100 shedding is crucial for inducing intrahepatic anti-HBV CD8 T cell responses and HBV clearance. J Hepatol. 2019;71(4):685\u201398.","journal-title":"J Hepatol"},{"issue":"2","key":"406_CR15","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1111\/imm.13189","volume":"160","author":"HM Wang","year":"2020","unstructured":"Wang HM, Zhang XH, Ye LQ, Zhang K, Yang NN, Geng S, Chen J, Zhao SX, Yang KL, Fan FF. Insufficient CD100 shedding contributes to suppression of CD8(+) T-cell activity in non-small cell lung cancer. Immunology. 2020;160(2):209\u201319.","journal-title":"Immunology"},{"issue":"5","key":"406_CR16","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0064265","volume":"8","author":"Q Lu","year":"2013","unstructured":"Lu Q, Dong N, Wang Q, Yi W, Wang Y, Zhang S, Gu H, Zhao X, Tang X, Jin B, et al. Increased levels of plasma soluble Sema4D in patients with heart failure. PLoS One. 2013;8(5):e64265.","journal-title":"PLoS One"},{"issue":"4","key":"406_CR17","doi-asserted-by":"publisher","first-page":"603","DOI":"10.1002\/ehf2.12275","volume":"5","author":"N Willner","year":"2018","unstructured":"Willner N, Goldberg Y, Schiff E, Vadasz Z. Semaphorin 4D levels in heart failure patients: a potential novel biomarker of acute heart failure? ESC Heart Fail. 2018;5(4):603\u20139.","journal-title":"ESC Heart Fail"},{"key":"406_CR18","doi-asserted-by":"publisher","first-page":"2912","DOI":"10.12659\/MSM.895441","volume":"21","author":"L Xiang","year":"2015","unstructured":"Xiang L, You T, Chen J, Xu W, Jiao Y. Serum soluble Semaphorin 4D is associated with left atrial diameter in patients with atrial fibrillation. Med Sci Monit. 2015;21:2912\u20137.","journal-title":"Med Sci Monit"},{"issue":"4","key":"406_CR19","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1042\/CS20090226","volume":"118","author":"OS Dhillon","year":"2009","unstructured":"Dhillon OS, Khan SQ, Narayan HK, Ng KH, Mohammed N, Quinn PA, Squire IB, Davies JE, Ng LL. Matrix metalloproteinase-2 predicts mortality in patients with acute coronary syndrome. Clin Sci (Lond). 2009;118(4):249\u201357.","journal-title":"Clin Sci (Lond)"},{"issue":"2","key":"406_CR20","first-page":"299","volume":"32","author":"H Sun","year":"2018","unstructured":"Sun H, Zhang J, Zheng Y, Shang S. Expressions and clinical significance of factors related to acute coronary syndrome. J Biol Regul Homeost Agents. 2018;32(2):299\u2013305.","journal-title":"J Biol Regul Homeost Agents"},{"issue":"7","key":"406_CR21","doi-asserted-by":"publisher","first-page":"3365","DOI":"10.4049\/jimmunol.1301522","volume":"192","author":"F Ma","year":"2014","unstructured":"Ma F, Feng J, Zhang C, Li Y, Qi G, Li H, Wu Y, Fu Y, Zhao Y, Chen H, et al. The requirement of CD8+ T cells to initiate and augment acute cardiac inflammatory response to high blood pressure. J Immunol. 2014;192(7):3365\u201373.","journal-title":"J Immunol"},{"key":"406_CR22","doi-asserted-by":"publisher","first-page":"2665","DOI":"10.3389\/fimmu.2018.02665","volume":"9","author":"C Groschel","year":"2018","unstructured":"Groschel C, Sasse A, Monecke S, Rohrborn C, Elsner L, Didie M, Reupke V, Bunt G, Lichtman AH, Toischer K, et al. CD8(+)-T cells with specificity for a model antigen in Cardiomyocytes can become activated after transverse aortic constriction but do not accelerate progression to heart failure. Front Immunol. 2018;9:2665.","journal-title":"Front Immunol"},{"key":"406_CR23","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1016\/j.molimm.2018.05.015","volume":"101","author":"L Zhang","year":"2018","unstructured":"Zhang L, Wang Z, Wang D, Zhu J, Wang Y. CD8(+)CD28(+) T cells might mediate injury of cardiomyocytes in acute myocardial infarction. Mol Immunol. 2018;101:74\u20139.","journal-title":"Mol Immunol"},{"issue":"4","key":"406_CR24","doi-asserted-by":"publisher","first-page":"466","DOI":"10.1038\/cmi.2014.74","volume":"12","author":"H Tae Yu","year":"2015","unstructured":"Tae Yu H, Youn JC, Lee J, Park S, Chi HS, Lee J, Choi C, Park S, Choi D, Ha JW, Shin EC. Characterization of CD8(+)CD57(+) T cells in patients with acute myocardial infarction. Cell Mol Immunol. 2015;12(4):466\u201373.","journal-title":"Cell Mol Immunol"},{"issue":"3","key":"406_CR25","doi-asserted-by":"publisher","first-page":"H581","DOI":"10.1152\/ajpheart.00112.2019","volume":"317","author":"DV Ilatovskaya","year":"2019","unstructured":"Ilatovskaya DV, Pitts C, Clayton J, Domondon M, Troncoso M, Pippin S, DeLeon-Pennell KY. CD8(+) T-cells negatively regulate inflammation post-myocardial infarction. Am J Physiol Heart Circ Physiol. 2019;317(3):H581\u201396.","journal-title":"Am J Physiol Heart Circ Physiol"},{"issue":"4","key":"406_CR26","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1038\/s41577-019-0150-7","volume":"19","author":"MK Maini","year":"2019","unstructured":"Maini MK. CD8(+) T cells cure without killing. Nat Rev Immunol. 2019;19(4):201.","journal-title":"Nat Rev Immunol"},{"issue":"4","key":"406_CR27","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.1002645","volume":"8","author":"JC Silverio","year":"2012","unstructured":"Silverio JC, Pereira IR, Cipitelli Mda C, Vinagre NF, Rodrigues MM, Gazzinelli RT, Lannes-Vieira J. CD8+ T-cells expressing interferon gamma or perforin play antagonistic roles in heart injury in experimental Trypanosoma cruzi-elicited cardiomyopathy. PLoS Pathog. 2012;8(4):e1002645.","journal-title":"PLoS Pathog"},{"key":"406_CR28","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1016\/j.clim.2017.09.010","volume":"191","author":"Z Vadasz","year":"2018","unstructured":"Vadasz Z, Elbirt D, Radian S, Bezalel-Rosenberg S, Mahlab-Guri K, Toubi E, Asher I, Sthoeger Z. Low levels of the immunoregulator Semaphorin 4D (CD100) in sera of HIV patients. Clin Immunol. 2018;191:88\u201393.","journal-title":"Clin Immunol"},{"issue":"8","key":"406_CR29","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0203419","volume":"13","author":"R Correa-Rocha","year":"2018","unstructured":"Correa-Rocha R, Lopez-Abente J, Gutierrez C, Perez-Fernandez VA, Prieto-Sanchez A, Moreno-Guillen S, Munoz-Fernandez MA, Pion M. CD72\/CD100 and PD-1\/PD-L1 markers are increased on T and B cells in HIV-1+ viremic individuals, and CD72\/CD100 axis is correlated with T-cell exhaustion. PLoS One. 2018;13(8):e0203419.","journal-title":"PLoS One"},{"issue":"9","key":"406_CR30","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0073958","volume":"8","author":"B Liu","year":"2013","unstructured":"Liu B, Ma Y, Yi J, Xu Z, Zhang YS, Zhang C, Zhuang R, Yu H, Wang J, Yang A, et al. Elevated plasma soluble Sema4D\/CD100 levels are associated with disease severity in patients of hemorrhagic fever with renal syndrome. PLoS One. 2013;8(9):e73958.","journal-title":"PLoS One"},{"issue":"23","key":"406_CR31","doi-asserted-by":"publisher","first-page":"11834","DOI":"10.1128\/JVI.01610-15","volume":"89","author":"B Liu","year":"2015","unstructured":"Liu B, Ma Y, Zhang Y, Zhang C, Yi J, Zhuang R, Yu H, Yang A, Zhang Y, Jin B. CD8low CD100- T cells identify a novel CD8 T cell subset associated with viral control during human Hantaan virus infection. J Virol. 2015;89(23):11834\u201344.","journal-title":"J Virol"},{"key":"406_CR32","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1016\/j.lfs.2019.01.021","volume":"219","author":"H Gong","year":"2019","unstructured":"Gong H, Lyu X, Li S, Chen R, Hu M, Zhang X. sSema4D levels are increased in coronary heart disease and associated with the extent of coronary artery stenosis. Life Sci. 2019;219:329\u201335.","journal-title":"Life Sci"},{"issue":"1","key":"406_CR33","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1177\/0300060516676136","volume":"45","author":"BJ Li","year":"2017","unstructured":"Li BJ, He Y, Zhang Y, Guo YH, Zhou Y, Zhang PX, Wang W, Zhao JR, Li JG, Zuo WZ, et al. Interferon-alpha-induced CD100 on naive CD8(+) T cells enhances antiviral responses to hepatitis C infection through CD72 signal transduction. J Int Med Res. 2017;45(1):89\u2013100.","journal-title":"J Int Med Res"},{"issue":"5","key":"406_CR34","doi-asserted-by":"publisher","first-page":"1621","DOI":"10.1073\/pnas.0606344104","volume":"104","author":"L Zhu","year":"2007","unstructured":"Zhu L, Bergmeier W, Wu J, Jiang H, Stalker TJ, Cieslak M, Fan R, Boumsell L, Kumanogoh A, Kikutani H, et al. Regulated surface expression and shedding support a dual role for semaphorin 4D in platelet responses to vascular injury. Proc Natl Acad Sci U S A. 2007;104(5):1621\u20136.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"6","key":"406_CR35","doi-asserted-by":"publisher","first-page":"1481","DOI":"10.1002\/art.39086","volume":"67","author":"Y Yoshida","year":"2015","unstructured":"Yoshida Y, Ogata A, Kang S, Ebina K, Shi K, Nojima S, Kimura T, Ito D, Morimoto K, Nishide M, et al. Semaphorin 4D contributes to rheumatoid arthritis by inducing inflammatory cytokine production: pathogenic and therapeutic implications. Arthritis Rheum. 2015;67(6):1481\u201390.","journal-title":"Arthritis Rheum"},{"issue":"9","key":"406_CR36","doi-asserted-by":"publisher","first-page":"6899","DOI":"10.1074\/jbc.M609570200","volume":"282","author":"JR Basile","year":"2007","unstructured":"Basile JR, Holmbeck K, Bugge TH, Gutkind JS. MT1-MMP controls tumor-induced angiogenesis through the release of semaphorin 4D. J Biol Chem. 2007;282(9):6899\u2013905.","journal-title":"J Biol Chem"},{"key":"406_CR37","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1016\/j.clim.2015.12.012","volume":"163","author":"KT Maleki","year":"2016","unstructured":"Maleki KT, Cornillet M, Bjorkstrom NK. Soluble SEMA4D\/CD100: a novel immunoregulator in infectious and inflammatory diseases. Clin Immunol. 2016;163:52\u20139.","journal-title":"Clin Immunol"},{"issue":"7","key":"406_CR38","doi-asserted-by":"publisher","first-page":"4341","DOI":"10.4049\/jimmunol.166.7.4341","volume":"166","author":"A Elhabazi","year":"2001","unstructured":"Elhabazi A, Delaire S, Bensussan A, Boumsell L, Bismuth G. Biological activity of soluble CD100. I. the extracellular region of CD100 is released from the surface of T lymphocytes by regulated proteolysis. J Immunol. 2001;166(7):4341\u20137.","journal-title":"J Immunol"},{"issue":"1","key":"406_CR39","first-page":"297","volume":"23","author":"L Zhou","year":"2019","unstructured":"Zhou L, Kou DQ. Correlation between acute myocardial infarction complicated with cerebral infarction and expression levels of MMP-2 and MMP-9. Eur Rev Med Pharmacol Sci. 2019;23(1):297\u2013302.","journal-title":"Eur Rev Med Pharmacol Sci"},{"issue":"1","key":"406_CR40","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1016\/j.ijcard.2004.12.024","volume":"105","author":"R Nakaya","year":"2005","unstructured":"Nakaya R, Uzui H, Shimizu H, Nakano A, Mitsuke Y, Yamazaki T, Ueda T, Lee JD. Pravastatin suppresses the increase in matrix metalloproteinase-2 levels after acute myocardial infarction. Int J Cardiol. 2005;105(1):67\u201373.","journal-title":"Int J Cardiol"},{"issue":"11","key":"406_CR41","doi-asserted-by":"publisher","first-page":"2396","DOI":"10.1016\/j.jid.2017.07.818","volume":"137","author":"Y Ke","year":"2017","unstructured":"Ke Y, Dang E, Shen S, Zhang T, Qiao H, Chang Y, Liu Q, Wang G. Semaphorin4D drives CD8(+) T-cell Lesional trafficking in Oral lichen Planus via CXCL9\/CXCL10 Upregulations in Oral keratinocytes. J Invest Dermatol. 2017;137(11):2396\u2013406.","journal-title":"J Invest Dermatol"},{"issue":"8","key":"406_CR42","doi-asserted-by":"publisher","DOI":"10.4161\/21624011.2014.954893","volume":"3","author":"S Boegel","year":"2014","unstructured":"Boegel S, Lower M, Bukur T, Sahin U, Castle JC. A catalog of HLA type, HLA expression, and neo-epitope candidates in human cancer cell lines. Oncoimmunology. 2014;3(8):e954893.","journal-title":"Oncoimmunology"}],"container-title":["BMC Immunology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12865-021-00406-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12865-021-00406-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12865-021-00406-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,2,20]],"date-time":"2021-02-20T09:14:22Z","timestamp":1613812462000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcimmunol.biomedcentral.com\/articles\/10.1186\/s12865-021-00406-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,2,16]]},"references-count":42,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,12]]}},"alternative-id":["406"],"URL":"https:\/\/doi.org\/10.1186\/s12865-021-00406-y","relation":{},"ISSN":["1471-2172"],"issn-type":[{"value":"1471-2172","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,2,16]]},"assertion":[{"value":"7 December 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 February 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 February 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The study protocol was approved by Ethical Committee of Zhengzhou Central Hospital Affiliated to Zhengzhou University, and was conformed to the ethical guidelines of the 1975 Declaration of Helsinki (6th revision, 2008). Informed consents were obtained from all enrolled subjects or legal guardians.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"13"}}